IDH1 and central nervous system cancer: Further subgroup analysis by IDH-1 mutation status showed that IDH-1-wildtype gliomas had significantly higher abnormality index values than IDH-1-mutant tumors (t = 3.17, p = 0.003), independent of tumor volume (ANCOVA, p = 0.005) [19].